ISSN: 2278-0238

Revista internacional de investigación y desarrollo en farmacia y ciencias biológicas

Acceso abierto

Nuestro grupo organiza más de 3000 Series de conferencias Eventos cada año en EE. UU., Europa y América. Asia con el apoyo de 1.000 sociedades científicas más y publica más de 700 Acceso abierto Revistas que contienen más de 50.000 personalidades eminentes, científicos de renombre como miembros del consejo editorial.

Revistas de acceso abierto que ganan más lectores y citas
700 revistas y 15 000 000 de lectores Cada revista obtiene más de 25 000 lectores

Abstracto

Applications of Quality by Design (QbD) in formulation development

Devendra Ridhurkar

The main objective of pharmaceutical development is to design a quality product and its manufacturing process to consistently deliver the intended performance of the product. Pharmaceutical industry realized that Quality by Design (QbD) principles, when implemented, lead to a successful product development, subsequent prompt regulatory approval, reduce exhaustive validation burden, and    significantly reduce postapproval changes and also helps to build a quality in all pharmaceutical products. Hence the application of QbD in pharmaceutical product development is now a thrust area for the regulatory authorities and the pharmaceutical industry. International Conference on Harmonization and United States Food and Drug Administration (USFDA) emphasized the principles and applications of QbD in pharmaceutical development in their guidance for the industry. Target product quality profile, critical quality attributes, risk assessments, design space, control strategy, product lifecycle management, and continual improvement are the key elements of QbD. Throughout designing and development of a product with QbD, it is essential to define desire product performance profile Target product profile (TPP), Target product Quality profile(TPQP) and identify Critical quality attributed (CQA) leads to recognize the impact of raw material,Critical material attributes (CMA), Critical process parameter (CPP), on the CQA’s and identification and source of variability.